Revvity, Inc. (RVTY)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Revvity, Inc. (RVTY)

Go deeper and ask any question about RVTY

Company Performance

Current Price

as of Sep 13, 2024

$122.03

P/E Ratio

68.78

Market Cap

$15.05B

Description

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.

Metrics

Overview

  • HQWaltham, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerRVTY
  • Price$122.03+1.56%

Trading Information

  • Market Cap$15.05B
  • Float99.60%
  • Average Daily Volume (1m)590,364
  • Average Daily Volume (3m)775,145
  • EPS$1.78

Company

  • Revenue$2.71B
  • Rev Growth (1yr)-2.45%
  • Net Income$72.61M
  • Gross Margin55.73%
  • EBITDA Margin30.18%
  • EBITDA$208.77M
  • EV$14.99B
  • EV/Revenue5.54
  • P/E68.78
  • P/S5.56